Articles published by Sesen Bio
![](https://mms.businesswire.com/media/20221107005373/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20220808005070/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20220718005162/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Announces Strategic Decision to Pause Clinical Development of Vicineum™ in the US
July 18, 2022
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20220509005287/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20220503005367/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20220228005267/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20220110005249/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Further Enhances Team with Key Hires
January 10, 2022
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20211129005227/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20211123005525/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20211108005378/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20211101005227/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Announces Productive CMC Type A Meeting with the FDA
November 01, 2021
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20211012005216/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Expands CMC and Clinical Teams
October 12, 2021
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20210813005377/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Receives Complete Response Letter from FDA for Vicineum™ (oportuzumab monatox-qqrs)
August 13, 2021
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20210811005073/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210809005157/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Reports Second Quarter 2021 Financial Results and Significant Global Progress for Vicineum™
August 09, 2021
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20210805005094/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210726005194/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210721005283/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210720005810/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210714005347/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210702005039/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210602005300/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210601005318/en/718592/4/Sesen_Logo.jpg)
Sesen Bio Strengthens Senior Leadership Team
June 01, 2021
From Sesen Bio
Via Business Wire
Tickers
SESN
![](https://mms.businesswire.com/media/20210521005471/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210510005219/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210504005718/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210503005387/en/718592/4/Sesen_Logo.jpg)
![](https://mms.businesswire.com/media/20210416005546/en/718592/4/Sesen_Logo.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.